Created in 2008 (United States), THALIDOMIDE PHARMION own 126 sister brands and 17478 competing brands. The THALIDOMIDE PHARMION brand is owned by Celgene, a company listed in New York. THALIDOMIDE PHARMION belongs to the Drug Manufacturers business sector.

THALIDOMIDE PHARMION is a brand of Celgene () Sustainability

International deposit : 2008 Business sector Drug Manufacturers
Here is the evolution of interest in Celgene "sustainability" criteria around the world over the past five years. The graph shows the evolution of the search rate over time, where the value 100 indicates the week with the most searches.
What is the brand's web response on its sustainability
Result of Google's query: "THALIDOMIDE PHARMION sustainability"
Sustainability -> Share price